secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2026-09-11T11:48:13+00:00
Accession:  0001140361-26-036277
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics corrects 3-month BCVA data in OPGx-BEST1 Cohort 1; mixed outcomes across 5 patients
--------------------------------------------------------------------------------

- Corrected 3-month BCVA changes: 101-101 treated eye +12 letters, fellow eye +4 letters.
- 101-104 treated +1 letter, fellow -7; 102-101 treated -10, fellow -8 letters.
- 102-102 treated +2 letters, fellow -5; 101-106 treated +6, fellow +2 letters.
- Revision fixes immaterial logMAR-to-ETDRS translation error on Slide 15; high-res microperimetry grids added to appendix.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126036277/0001140361-26-036277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036126036277/ef20081922_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-036277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer